Stephen J. McAndrew - 17 Feb 2025 Form 3 Insider Report for Sonnet BioTherapeutics Holdings, Inc. (SONN)

Role
Chief Business Officer
Signature
/s/ Stephen J. McAndrew
Issuer symbol
SONN
Transactions as of
17 Feb 2025
Net transactions value
$0
Form type
3
Filing time
21 Feb 2025, 16:05:25 UTC
Next filing
15 Jul 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding SONN Common Stock 446 17 Feb 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 424 shares of Common Stock underlying vested restricted stock units that have not been issued.

Remarks:

Exhibit 24 - Power of Attorney